Ignite Creation Date:
2024-10-25 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06562036
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-17
Brief Title:
Efficacy of Milrinone With Sildenafil in Persistent Pulmonary Hypertension in Children
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension A Single-Center Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Neonates with persistent pulmonary hypertension PPH should be administered inhaled nitric oxide iNO and extracorporeal membrane oxygenation ECMO but these are not available in most resource-constrained settings like ours This study was planned to compare the outcomes of Milrinone plus Sildenafil versus Sildenafil alone in the treatment of PPH in neonates
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None